BACKGROUND: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infections in humans. Despite the virus' public health importance and a wealth of sequence data, basic aspects of HCV molecular evolution remain poorly understood. Here we investigate three sets of whole HCV genomes in order to directly compare the evolution of whole HCV genomes at different biological levels: within- and among-hosts. We use a powerful Bayesian inference framework that incorporates both among-lineage rate heterogeneity and phylogenetic uncertainty into estimates of evolutionary parameters. RESULTS: Most of the HCV genome evolves at ~0.001 substitutions/site/year, a rate typical of RNA viruses. The antigenically-important E1/E2 genom...
Hepatitis C virus (HCV) persists in the majority of those infected despite host immune responses. Ev...
Understanding within-host evolution is critical for predicting viral evolutionary outcomes, yet such...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
Background: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infecti...
Background: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infecti...
BACKGROUND: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infecti...
BACKGROUND: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infecti...
Despite major breakthroughs in the treatment of HCV infection in recent years, we have a limited und...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
Background Despite recent breakthroughs in treatment of hepatitis C virus (HCV) infection, we have l...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
Background Despite recent breakthroughs in treatment of hepatitis C virus (HCV) infection, we have l...
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 are important targets for the host immune r...
Hepatitis C virus (HCV) persists in the majority of those infected despite host immune responses. Ev...
Understanding within-host evolution is critical for predicting viral evolutionary outcomes, yet such...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
Background: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infecti...
Background: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infecti...
BACKGROUND: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infecti...
BACKGROUND: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infecti...
Despite major breakthroughs in the treatment of HCV infection in recent years, we have a limited und...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
Background Despite recent breakthroughs in treatment of hepatitis C virus (HCV) infection, we have l...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...
Background Despite recent breakthroughs in treatment of hepatitis C virus (HCV) infection, we have l...
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 are important targets for the host immune r...
Hepatitis C virus (HCV) persists in the majority of those infected despite host immune responses. Ev...
Understanding within-host evolution is critical for predicting viral evolutionary outcomes, yet such...
The treatment of HCV infection has seen significant progress, particularly since the approval of new...